000			02044 a2200577 4500
005			20250516055717.0
264		0	_c20120813
008			201208s 0 0 eng d
022			_a1099-1557
024	7		_a10.1002/pds.2251 _2doi
040			_aNLM _beng _cNLM
100	1		_aGroenwold, Rolf H H
245	0	0	_aBalance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction. _h[electronic resource]
260			_bPharmacoepidemiology and drug safety _cNov 2011
300			_a1130-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcademic Medical Centers
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdrenergic beta-Agonists _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Asthmatic Agents _xtherapeutic use
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBias
650	0	4	_aCardiovascular Diseases _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aComorbidity
650	0	4	_aComputer Simulation _xstatistics & numerical data
650	0	4	_aConfounding Factors, Epidemiologic
650	0	4	_aDelayed-Action Preparations _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aPropensity Score
650	0	4	_aProportional Hazards Models
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdrug therapy
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisk
650	0	4	_aStatistics, Nonparametric
700	1		_ade Vries, Frank
700	1		_ade Boer, Anthonius
700	1		_aPestman, Wiebe R
700	1		_aRutten, Frans H
700	1		_aHoes, Arno W
700	1		_aKlungel, Olaf H
773	0		_tPharmacoepidemiology and drug safety _gvol. 20 _gno. 11 _gp. 1130-7
856	4	0	_uhttps://doi.org/10.1002/pds.2251 _zAvailable from publisher's website
999			_c21190998 _d21190998